Citadel Advisors’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Citadel Advisors’s Portfolio AMTI Stock Details AMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23,576	Closed	-$9.9K	–	15829
2022 Q4	$9.9K	Sell	23,576 -180,086	-88%	-$181K	﹤0.01%	13656
2022 Q3	$198K	Sell	203,662 -115,903	-36%	-$205K	﹤0.01%	10413
2022 Q2	$930K	Buy	319,565 +229,114	+253%	+$963K	﹤0.01%	7194
2022 Q1	$680K	Sell	90,451 -95,881	-51%	-$794K	﹤0.01%	8642
2021 Q4	$2.6M	Buy	186,332 +13,325	+8%	+$263K	﹤0.01%	5620
2021 Q3	$4.47M	Buy	+173,007	New	+$5.48M	﹤0.01%	4519
2020 Q3	–	Sell	-717,330	Closed	-$18M	–	10940
2020 Q2	$18M	Buy	+717,330	New	+$18.1M	0.01%	1594

Other funds holding AMTI

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors's AMTI Position: Q1 2023 in Review

Citadel Advisors sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2023, closing a stake of 23,576 shares — an estimated $9.9K sold.

Citadel Advisors first reported a position in AMTI in Q2 2020 and held it in 7 quarters. The position peaked at $18M in Q2 2020. 35 funds tracked by Wall St. Rank hold AMTI as of Q1 2023.

Citadel Advisors reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Citadel Advisors sold 23,576 Applied Molecular Transport Inc. Common Stock shares in Q1 2023, an estimated $9.9K.
Citadel Advisors first reported a position in Applied Molecular Transport Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Citadel Advisors's Applied Molecular Transport Inc. Common Stock position peaked at $18M in Q2 2020.
35 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.